SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD.

Cash flow Shanghai MicroPort MedBot (Group) Co., Ltd.

Equities

2252

CNE100004QP1

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. Other stock markets 08:08:09 12/12/2025 GMT			5-day change	1st Jan Change
21.12 ^HKD	+2.03%		-6.80%	+122.08%

11-25	Shanghai MicroPort MedBot Co., Ltd. Announces Board and Committee Changes	CI
11-05	Shanghai Microport Medbot Co., Ltd. Announces Board Changes	CI

fd5afe4f1c5b9f07b1b6.06ouRFXooMrKN3A72d3dAja7XGL_6CT9Bzr0WUkgL0o.mOtjPmO464j9R11eu6qzcFHPNwatmWGUcFSXGhxzQR2LkkssJKPOrIVDMQ

Published financial data: SHANGHAI MICROPORT MEDBOT (GROUP) CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	-	2.15M	21.6M	105M	257M
Total Revenues	-	2.15M	21.6M	105M	257M
Cost of Goods Sold, Total	-	1.23M	15.04M	89.9M	171M
Gross Profit	-	919K	6.56M	14.69M	86.22M
Selling General & Admin Expenses, Total	29.58M	187M	355M	365M	263M
R&D Expenses	135M	393M	756M	569M	309M
Other Operating Expenses	-2.36M	-8.74M	-6.78M	-18.04M	-3.27M
Other Operating Expenses, Total	163M	571M	1.1B	916M	569M
Operating Income	-163M	-570M	-1.1B	-901M	-482M
Interest Expense, Total	-49.13M	-5.29M	-11.13M	-18.41M	-21.51M
Interest And Investment Income	8.09M	22.07M	26.65M	8.87M	2.2M
Net Interest Expenses	-41.04M	16.78M	15.53M	-9.53M	-19.31M
Income (Loss) On Equity Invest.	-1.68M	-27.38M	-39.66M	-29.8M	-20.24M
Currency Exchange Gains (Loss)	-676K	-9.11M	2.04M	201K	-534K
Other Non Operating Income (Expenses)	-3.31M	45.38M	-27.22M	-42.71M	5K
EBT, Excl. Unusual Items	-209M	-544M	-1.15B	-983M	-523M
Gain (Loss) On Sale Of Investments	-	-	-	-	-116M
Other Unusual Items	-	-40.53M	-	-40.45M	-8.1M
EBT, Incl. Unusual Items	-209M	-585M	-1.15B	-1.02B	-647M
Earnings From Continuing Operations	-209M	-585M	-1.15B	-1.02B	-647M
Net Income to Company	-209M	-585M	-1.15B	-1.02B	-647M
Minority Interest	416K	1.59M	6.48M	11.36M	4.7M
Net Income - (IS)	-209M	-583M	-1.14B	-1.01B	-642M
Preferred Dividend and Other Adjustments	-5.98M	-	-	-	-
Net Income to Common Incl Extra Items	-203M	-583M	-1.14B	-1.01B	-642M
Net Income to Common Excl. Extra Items	-203M	-583M	-1.14B	-1.01B	-642M
Per Share Items
Net EPS - Basic	-0.27	-0.63	-1.19	-1.06	-0.66
Basic EPS - Continuing Operations	-0.27	-0.63	-1.19	-1.06	-0.66
Basic Weighted Average Shares Outstanding	756M	920M	959M	959M	967M
Net EPS - Diluted	-0.27	-0.63	-1.19	-1.06	-0.66
Diluted EPS - Continuing Operations	-0.27	-0.63	-1.19	-1.06	-0.66
Diluted Weighted Average Shares Outstanding	756M	920M	959M	959M	967M
Normalized Basic EPS	-0.17	-0.37	-0.74	-0.63	-0.33
Normalized Diluted EPS	-0.17	-0.37	-0.74	-0.63	-0.33
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	-161M	-563M	-1.05B	-840M	-408M
EBITA	-163M	-570M	-1.1B	-901M	-482M
EBIT	-163M	-570M	-1.1B	-901M	-482M
EBITDAR	-159M	-559M	-1.05B	-833M	-405M
Normalized Net Income	-130M	-338M	-710M	-603M	-322M
Interest on Long-Term Debt	469K	5.29M	11.13M	6.97M	4.45M
Supplemental Operating Expense Items
Selling and Marketing Expenses	2.69M	79.19M	184M	238M	208M
General and Administrative Expenses	24.72M	107M	170M	126M	55.28M
Research And Development Expense From Footnotes	135M	393M	756M	569M	309M
Net Rental Expense, Total	2.16M	3.38M	6.74M	7.04M	3.27M
Imputed Operating Lease Interest Expense	53.59M	1.27M	2.82M	2.54M	875K
Imputed Operating Lease Depreciation	-51.43M	2.1M	3.92M	4.5M	2.4M
Stock-Based Comp., R&D Exp. (Total)	-	56.22M	89.9M	72.36M	37.84M
Stock-Based Comp., S&M Exp. (Total)	-	12.69M	18.02M	12.49M	7.05M
Stock-Based Comp., G&A Exp. (Total)	-	22.28M	29M	27.03M	3.28M
Stock-Based Comp., Other (Total)	15.78M	-	-	-	-
Total Stock-Based Compensation	15.78M	91.2M	137M	112M	48.16M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.5B	1.94B	748M	508M	612M
Total Cash And Short Term Investments	1.5B	1.94B	748M	508M	612M
Accounts Receivable, Total	-	87K	-	4.97M	92.84M
Other Receivables	11.16M	7.96M	73.33M	36.99M	-
Total Receivables	11.16M	8.04M	73.33M	41.96M	92.84M
Inventory	-	110M	250M	230M	151M
Other Current Assets, Total	6.57M	35.48M	27.05M	14.87M	-
Total Current Assets	1.52B	2.09B	1.1B	794M	857M
Gross Property Plant And Equipment	46.41M	403M	624M	569M	583M
Accumulated Depreciation	-7.7M	-42.48M	-133M	-202M	-285M
Net Property Plant And Equipment	38.71M	361M	492M	367M	297M
Long-term Investments	124M	260M	285M	215M	78.94M
Goodwill	1.48M	1.48M	1.48M	1.48M	1.48M
Other Intangibles, Total	565K	3.07M	7.05M	9.54M	3.97M
Accounts Receivable Long-Term	-	-	-	-	2.58M
Other Long-Term Assets, Total	24.75M	71.98M	46.44M	40.62M	38.15M
Total Assets	1.7B	2.79B	1.93B	1.43B	1.28B
Liabilities
Accounts Payable, Total	28.34M	83.6M	125M	74.25M	81.64M
Accrued Expenses, Total	13.92M	39.41M	64.09M	78.66M	53.43M
Short-term Borrowings	356K	356K	356K	356K	-
Current Portion of Long-Term Debt	-	-	-	375M	245M
Current Portion of Leases	7.29M	52.86M	58.22M	47.88M	34.51M
Unearned Revenue Current, Total	-	-	8.49M	11.12M	8.72M
Other Current Liabilities	179M	58.24M	69.61M	97.65M	79.94M
Total Current Liabilities	229M	234M	325M	685M	503M
Long-Term Debt	-	-	33.1M	99.7M	389M
Long-Term Leases	11.59M	152M	129M	72.51M	22.28M
Unearned Revenue Non Current	22.4M	15.05M	34.8M	68.59M	106M
Other Non Current Liabilities	-	397K	397K	82K	637K
Total Liabilities	263M	402M	522M	926M	1.02B
Common Stock, Total	900M	959M	959M	959M	1.01B
Additional Paid In Capital	619M	2.01B	2.01B	2.01B	2.31B
Retained Earnings	-135M	-718M	-1.86B	-2.87B	-3.51B
Comprehensive Income and Other	59.17M	146M	311M	425M	474M
Total Common Equity	1.44B	2.39B	1.42B	519M	278M
Minority Interest	-1.4M	-2.99M	-9.78M	-17.72M	-20.52M
Total Equity	1.44B	2.39B	1.41B	502M	258M
Total Liabilities And Equity	1.7B	2.79B	1.93B	1.43B	1.28B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	900M	959M	959M	959M	1.01B
ECS Total Common Shares Outstanding	900M	959M	959M	959M	1.01B
Book Value / Share	1.6	2.5	1.48	0.54	0.28
Tangible Book Value	1.44B	2.39B	1.41B	508M	273M
Tangible Book Value Per Share	1.6	2.49	1.47	0.53	0.27
Total Debt	19.24M	205M	220M	596M	691M
Net Debt	-1.48B	-1.74B	-528M	88.09M	79.1M
Debt Equivalent Oper. Leases	17.28M	27M	53.9M	56.29M	26.18M
Minority Interest, Total (Incl. Fin. Div)	-1.4M	-2.99M	-9.78M	-17.72M	-20.52M
Equity Method Investments, Total	85.43M	124M	175M	148M	11.89M
Account Code - Inventory Valuation	5	6	6	6	6
Inventories - Raw Materials, Total	-	95.38M	162M	111M	84.15M
Inventories - Work In Process, Total	-	7.17M	18.26M	54.02M	35.15M
Inventories - Finished Goods, Total	-	7.33M	70.2M	63.74M	32.18M
Inventories - Others	-	-	25K	407K	2K
Machinery, Total	12.09M	100M	239M	291M	352M
Full Time Employees	-	898	1.23K	646	443

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-209M	-583M	-1.14B	-1.01B	-642M
Depreciation & Amortization - CF	4.23M	34.9M	98.89M	109M	112M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	173K	590K
Depreciation & Amortization, Total	4.23M	34.9M	98.89M	109M	113M
Amortization of Deferred Charges, Total - (CF)	229K	474K	1.81M	2.66M	5.25M
(Gain) Loss From Sale Of Asset	10K	-	-1.92M	951K	8.07M
(Gain) Loss on Sale of Investments - (CF)	3.25M	-45.52M	26.98M	42.52M	-138K
(Income) Loss On Equity Investments - (CF)	1.68M	27.38M	39.66M	29.8M	20.24M
Stock-Based Compensation (CF)	15.78M	91.2M	137M	112M	48.16M
Other Operating Activities, Total	48.71M	14.72M	3.23M	43.4M	134M
Change In Accounts Receivable	-16.1M	-8.21M	-65.97M	39.47M	-33.58M
Change In Inventories	-	-110M	-141M	25.37M	78.02M
Change In Accounts Payable	33.97M	82.09M	85.1M	5.86M	-59.13M
Change in Unearned Revenues	18.02M	-7.45M	18.07M	31.66M	28.46M
Change in Other Net Operating Assets	-3.94M	-37.25M	39.15M	1.66M	2.7M
Cash from Operations	-103M	-540M	-898M	-568M	-298M
Capital Expenditure	-14.55M	-131M	-188M	-64.98M	-41.78M
Sale of Property, Plant, and Equipment	-	-	-	7.67M	477K
Sale (Purchase) of Intangible assets	-457K	-2.98M	-6.54M	-1.47M	-306K
Investment in Marketable and Equity Securities, Total	-	-263M	-70.21M	-	-
Other Investing Activities, Total	3K	-	-2.8M	399K	-5.99M
Cash from Investing	-15.01M	-397M	-268M	-58.38M	-47.6M
Short Term Debt Issued, Total	-	-	20M	-	99.09M
Long-Term Debt Issued, Total	-	-	33.1M	437M	838M
Total Debt Issued	-	-	53.1M	437M	938M
Short Term Debt Repaid, Total	-3.67M	-	-20M	-	-48.36M
Long-Term Debt Repaid, Total	-4.45M	-18.68M	-51.83M	-37.83M	-422M
Total Debt Repaid	-8.12M	-18.68M	-71.83M	-37.83M	-471M
Issuance of Common Stock	1.57B	1.45B	-	-	-
Other Financing Activities, Total	-466K	-39.95M	-9.21M	-13M	-16.73M
Cash from Financing	1.56B	1.39B	-27.95M	386M	450M
Foreign Exchange Rate Adjustments	-	-11.68M	1.38M	301K	285K
Net Change in Cash	1.44B	443M	-1.19B	-240M	105M
Supplemental Items
Cash Interest Paid	466K	4.57M	10.64M	17.16M	21.36M
Levered Free Cash Flow	42.86M	-542M	-762M	-358M	-187M
Unlevered Free Cash Flow	73.57M	-539M	-755M	-347M	-174M
Change In Net Working Capital	-170M	176M	112M	-59.47M	-3.7M
Net Debt Issued / Repaid	-8.12M	-18.68M	-18.73M	399M	467M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-11.4	-15.84	-29.04	-33.55	-22.28
Return on Total Capital	-13.55	-17.56	-32.47	-41.33	-29.47
Return On Equity %	-28.52	-30.51	-60.36	-107.2	-170.42
Return on Common Equity	-27.62	-30.39	-59.82	-104.5	-161.07
Margin Analysis
Gross Profit Margin %	-	42.74	30.38	14.05	33.52
SG&A Margin	-	8.68K	1.64K	348.77	102.32
EBITDA Margin %	-	-26.16K	-4.88K	-803.31	-158.72
EBITA Margin %	-	-26.5K	-5.08K	-861.5	-187.31
EBIT Margin %	-	-26.5K	-5.08K	-861.67	-187.54
Income From Continuing Operations Margin %	-	-27.19K	-5.31K	-978.59	-251.55
Net Income Margin %	-	-27.11K	-5.28K	-967.74	-249.72
Net Avail. For Common Margin %	-	-27.11K	-5.28K	-967.74	-249.72
Normalized Net Income Margin	-	-15.74K	-3.29K	-576.59	-125.13
Levered Free Cash Flow Margin	-	-25.23K	-3.53K	-342.41	-72.83
Unlevered Free Cash Flow Margin	-	-25.08K	-3.49K	-331.41	-67.6
Asset Turnover
Asset Turnover	-	0	0.01	0.06	0.19
Fixed Assets Turnover	-	0.01	0.05	0.24	0.77
Receivables Turnover (Average Receivables)	-	-	-	-	5.26
Inventory Turnover (Average Inventory)	-	-	0.08	0.37	0.9
Short Term Liquidity
Current Ratio	6.62	8.93	3.38	1.16	1.7
Quick Ratio	6.59	8.31	2.52	0.8	1.4
Operating Cash Flow to Current Liabilities	-0.45	-2.31	-2.76	-0.83	-0.59
Days Sales Outstanding (Average Receivables)	-	-	-	-	69.57
Days Outstanding Inventory (Average Inventory)	-	-	4.37K	974.4	407.65
Average Days Payable Outstanding	-	-	244.07	526.37	306.73
Cash Conversion Cycle (Average Days)	-	-	-	-	170.49
Long Term Solvency
Total Debt/Equity	1.33	8.58	15.65	118.74	268.29
Total Debt / Total Capital	1.32	7.9	13.53	54.28	72.85
LT Debt/Equity	0.8	6.35	11.49	34.32	159.73
Long-Term Debt / Total Capital	0.79	5.85	9.93	15.69	43.37
Total Liabilities / Total Assets	15.43	14.39	27.06	64.86	79.85
EBIT / Interest Expense	-3.31	-107.62	-98.6	-48.96	-22.43
EBITDA / Interest Expense	-3.22	-101.03	-89.71	-43.03	-17.2
(EBITDA - Capex) / Interest Expense	-3.52	-125.78	-106.63	-46.56	-19.14
Total Debt / EBITDA	-0.12	-0.38	-0.22	-0.75	-1.87
Net Debt / EBITDA	9.33	3.25	0.53	-0.11	-0.21
Total Debt / (EBITDA - Capex)	-0.11	-0.31	-0.19	-0.7	-1.68
Net Debt / (EBITDA - Capex)	8.55	2.61	0.44	-0.1	-0.19
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	904.79	384.15	145.95
Gross Profit, 1 Yr. Growth %	-	-	614.04	123.93	486.77
EBITDA, 1 Yr. Growth %	132.47	249.54	87.46	-20.32	-51.4
EBITA, 1 Yr. Growth %	131.16	250.36	92.57	-17.86	-46.52
EBIT, 1 Yr. Growth %	131.16	250.36	92.57	-17.84	-46.47
Earnings From Cont. Operations, 1 Yr. Growth %	199.84	179.28	96.11	-10.71	-36.78
Net Income, 1 Yr. Growth %	199.24	179.08	95.53	-11.2	-36.53
Normalized Net Income, 1 Yr. Growth %	198.88	159.53	109.79	-15.06	-46.62
Diluted EPS Before Extra, 1 Yr. Growth %	137.91	136.01	87.63	-11.2	-37.08
Accounts Receivable, 1 Yr. Growth %	-	-	-	-	1.77K
Inventory, 1 Yr. Growth %	-	-	127.95	-8.37	-34
Net Property, Plant and Equip., 1 Yr. Growth %	168.02	832.58	36.17	-25.34	-18.98
Total Assets, 1 Yr. Growth %	2.07K	63.81	-30.87	-26.02	-10.43
Tangible Book Value, 1 Yr. Growth %	5.43K	65.78	-41.01	-63.92	-46.36
Common Equity, 1 Yr. Growth %	5.36K	65.86	-40.76	-63.36	-46.45
Cash From Operations, 1 Yr. Growth %	111.6	424.53	66.23	-36.8	-47.5
Capital Expenditures, 1 Yr. Growth %	297.65	800.07	43.72	-65.48	-35.7
Levered Free Cash Flow, 1 Yr. Growth %	-	-1.37K	40.43	-52.98	-47.63
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-832.85	40	-54.08	-49.78
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-	597.48	245.08
Gross Profit, 2 Yr. CAGR %	-	-	-	299.86	262.48
EBITDA, 2 Yr. CAGR %	-	185.06	155.98	22.22	-37.77
EBITA, 2 Yr. CAGR %	-	184.59	159.75	25.77	-33.72
EBIT, 2 Yr. CAGR %	-	184.59	159.75	25.78	-33.68
Earnings From Cont. Operations, 2 Yr. CAGR %	-	189.38	134.03	32.33	-24.87
Net Income, 2 Yr. CAGR %	-	188.98	133.6	31.77	-24.93
Normalized Net Income, 2 Yr. CAGR %	-	178.51	133.34	33.5	-32.67
Diluted EPS Before Extra, 2 Yr. CAGR %	-	136.96	110.43	29.08	-25.25
Accounts Receivable, 2 Yr. CAGR %	-	-	-	655.74	-
Inventory, 2 Yr. CAGR %	-	-	-	44.52	-22.23
Net Property, Plant and Equip., 2 Yr. CAGR %	-	399.95	256.36	0.83	-22.22
Total Assets, 2 Yr. CAGR %	-	496.61	6.42	-28.48	-18.6
Tangible Book Value, 2 Yr. CAGR %	-	857.12	-1.11	-53.86	-56
Common Equity, 2 Yr. CAGR %	-	851.9	-0.88	-53.41	-55.7
Cash From Operations, 2 Yr. CAGR %	-	233.15	195.29	2.5	-42.4
Capital Expenditures, 2 Yr. CAGR %	-	498.26	259.67	-29.57	-52.89
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	321.57	-18.75	-50.41
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	220.31	-19.82	-52
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	-	392.76
Gross Profit, 3 Yr. CAGR %	-	-	-	-	354.39
EBITDA, 3 Yr. CAGR %	-	-	147.89	73.48	-10.13
EBITA, 3 Yr. CAGR %	-	-	149.84	76.96	-5.43
EBIT, 3 Yr. CAGR %	-	-	149.84	76.98	-5.39
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	154.18	69.74	3.45
Net Income, 3 Yr. CAGR %	-	-	153.7	69.22	3.29
Normalized Net Income, 3 Yr. CAGR %	-	-	153.41	66.61	-1.65
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	119.22	57.84	1.59
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-	921.87
Inventory, 3 Yr. CAGR %	-	-	-	-	11.3
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	224.07	111.65	-6.26
Total Assets, 3 Yr. CAGR %	-	-	190.87	-5.73	-22.91
Tangible Book Value, 3 Yr. CAGR %	-	-	278.08	-29.33	-51.49
Common Equity, 3 Yr. CAGR %	-	-	277.22	-28.86	-51.2
Cash From Operations, 3 Yr. CAGR %	-	-	164.24	76.63	-17.99
Capital Expenditures, 3 Yr. CAGR %	-	-	271.91	64.67	-31.67
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	102.92	-29.84
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	67.65	-31.42
Compound Annual Growth Rate Over Five Years
EBITDA, 5 Yr. CAGR %	-	-	-	-	42.61
EBITA, 5 Yr. CAGR %	-	-	-	-	46.94
EBIT, 5 Yr. CAGR %	-	-	-	-	46.98
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-	56.11
Net Income, 5 Yr. CAGR %	-	-	-	-	55.88
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-	49.14
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	42.55
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	83.12
Total Assets, 5 Yr. CAGR %	-	-	-	-	74.77
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	59.92
Common Equity, 5 Yr. CAGR %	-	-	-	-	60.15
Cash From Operations, 5 Yr. CAGR %	-	-	-	-	43.67
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	62.75